Rheumatology Journals

Rheumatology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Nam J et al. – Assessment of disease activity and severity is currently based on a combination of clinical and laboratory parameters that aid treatment decisions. Use of biomarkers may provide a more accurate means of objectively assessing the disease. This article reviews the role of biomarkers in the management of RA.

Related Articles

Pain in arthritis
European Journal of Pain, 11/17/09    Relevance Score: 94%

Certolizumab Pegol: In Rheumatoid Arthritis
BioDrugs, 11/11/09    Relevance Score: 94%

Enhanced Pain Perception in Rheumatoid Arthritis: Novel Considerations
Current Pain and Headache Reports, 11/06/09    Relevance Score: 94%

Anti-tumor Necrosis Factor Treatment Does Not Increase Cancer Risk In Rheumatoid Arthritis Patients, Study Finds
ScienceDaily, 10/30/09    Relevance Score: 94%

Anti-tumour necrosis factor therapy and B cells in rheumatoid arthritis
Arthritis Research & Therapy, 10/20/09    Relevance Score: 94%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address